Between chemotherapy and non-chemotherapy group, age at prostate cancer and CRPC diagnosis, TTCRPC, and PSA reduction rate (PSARR), the value of PSA and Hb were statistically different. This evidence concerns the gene GSTM1 and prostate cancer.